Mar 27 |
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
|
Mar 25 |
Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting
|
Mar 4 |
Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting
|
Jan 26 |
Nutriband CEO Publishes Letter to Shareholders
|
Jan 5 |
Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
|
Nov 8 |
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
|